Advancing Neurological Therapeutics: Clinical Updates from Biogen’s Neuroscience Pipeline
Time: 9:00 am
day: Day Two - Morning
Details:
- Highlights from key trials in Alzheimer’s disease, ALS, MS, and rare neuromuscular disorders
- Leveraging biomarkers to inform trial design and accelerate development
- Patient-centered approaches, adaptive trial designs, and lessons learned
